Contemporary management of ischemic priapism: A 12-year population-based analysis from a large US database

被引:1
|
作者
Licari, Leslie Claire [1 ,2 ]
Bologna, Eugenio [1 ,2 ]
Ditonno, Francesco [1 ]
Franco, Antonio [1 ]
Lasorsa, Francesco [1 ]
Bignante, Gabriele [1 ]
Proietti, Flavia [3 ]
Leonardo, Costantino [3 ]
Anele, Uzoma A. [4 ]
Cherullo, Edward E. [1 ]
Levine, Laurence A. [1 ]
Autorino, Riccardo [1 ]
Manfredi, Celeste [1 ,5 ]
机构
[1] Rush Univ, Dept Urol, Chicago, IL USA
[2] Sapienza Univ Rome, Policlin Umberto Hosp 1, Dept Maternal Child & Urol Sci, Rome, Italy
[3] Regina Elena Inst Canc Res, Dept Urol, Rome, Italy
[4] Univ Louisville, Sch Med, Dept Urol, Louisville, KY USA
[5] Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Specialized Surg, Unit Urol, Naples, Italy
关键词
erectile dysfunction; ischemic priapism; penile prosthesis; penile shunt; sickle cell disease; SICKLE-CELL-DISEASE; PENILE PROSTHESIS; FABRY DISEASE;
D O I
10.1111/andr.13740
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Background Priapism is a urological condition characterized by a persistent erection. The management varies based on its subclassifications. Despite established clinical guidelines for ischemic priapism, there is a lack of large-scale research focused on patient characteristics and management strategies. Objectives To analyze the contemporary management of ischemic priapism in the US, exploring patient demographics and clinical characteristics, as well as predictors of erectile dysfunction (ED) and penile prosthesis implantation (PPI). Materials and methods We performed a retrospective analysis of the PearlDiver Mariner database, reviewing records from 2010-2021. Adult males diagnosed with ischemic priapism were included. Data analysis covered demographic, clinical variables, and management strategies. Predictors of de novo ED and PPI were evaluated using multivariable logistic regression analysis. Results Of 36,120 patients, most (93%) received only medical management, and a minority underwent surgical interventions (penile shunt surgery [PSS], PPI or both). Medical management was typically effective, as 67.08% of the patients in this group experienced only one episode of priapism. However, de novo ED occurred in 16.57% of these patients. The majority of patients undergoing PPI had an inflatable prosthesis (81%). Older age (odds ratio, OR 1.02), the presence of metabolic diseases (OR 1.39), neurogenic disorders (OR 1.72), solid pelvic malignancies (OR 1.09), and multiple episodes of priapism were identified as significant predictors of de novo ED (all p < 0.05). Similarly, age (OR 1.03), the presence of metabolic diseases (OR 1.23), solid pelvic malignancies (OR 1.99), and multiple episodes of priapism were associated with higher likelihood of PPI (all p < 0.05). Conclusion Most cases of ischemic priapism are managed with the medical therapy. Less than 3% of patients with ischemic priapism receive PPI, and when this occurs an inflatable prosthesis is favored. Age, specific comorbidities, and multiple episodes of priapism appear to be significant predictors of ED and PPI.
引用
收藏
页码:811 / 820
页数:10
相关论文
共 3 条
  • [1] Exploring the Use of Exchange Transfusion in the Surgical Management of Priapism in Sickle Cell Disease: A Population-Based Analysis
    Ha, Albert S.
    Wallace, Brendan K.
    Miles, Caleb
    Raup, Valary
    Punjani, Nahid
    Badalato, Gina M.
    Alukal, Joseph P.
    JOURNAL OF SEXUAL MEDICINE, 2021, 18 (10) : 1788 - 1796
  • [2] Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the US population: a six-year population-based cohort analysis
    Zhou, Jifang
    Han, Jin
    Nutescu, Edith A.
    Galanter, William L.
    Walton, Surrey M.
    Gordeuk, Victor R.
    Saraf, Santosh L.
    Calip, Gregory S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (01) : 116 - 127
  • [3] Association between erectile dysfunction and the predicted 10-year risk for atherosclerosis cardiovascular disease among US men: a population-based study from the NHANES 2001-2004
    Mei, Yangyang
    Chen, Yiming
    Wang, Xiaogang
    Xu, Renfang
    Xu, Rui
    Feng, Xingliang
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15